Sushree Mohanty
I am Sushree Mohanty, a financial analyst with eight years of experience in finance, retail, and operations management. I first joined Market Realist in 2015. I covered macroeconomics, consumer stocks, and the real estate sector. Currently, I am fascinated with the cannabis industry. I love digging deeper into this vast marijuana sector and provide a detailed and interesting analysis. I have a bachelor’s degree in business management, specializing in finance. I am also a CFA Level 2 candidate.
Creativity is my forte. Besides financial writing, I also love writing on general topics, life-changing experiences, and spirituality. I am an artist-singer, painter, and dancer. I love traveling and learning about various cultures. I am also a fitness enthusiast and a fighter by passion.
Disclosure: I am in full compliance with all ethics and other policies for Market Realist research analysts. I am not invested in securities that I cover on Market Realist.
More From Sushree Mohanty
Earnings Report Archer Daniels Midland Reports Another Disappointing Quarter
In 3Q15, Archer Daniels Midland earned $684 million in operating profit, down $257 million from 3Q14. Its net revenue for the quarter was $16.6 billion.Earnings Report What Do Analysts Recommend for Archer Daniels Midland?
Now, ~8% gave Archer Daniels Midland a “buy” rating. No analysts rated it a “sell.” The average target price for the company fell to $36.60 as of April 26.Earnings Report Analyzing the Expectations for Cal-Maine Foods in Fiscal 3Q16
Cal-Maine Foods will report its fiscal 3Q16 results on March 28. Cal-Maine’s stock has gained 2% since its last quarter earnings release on December 23, 2015.Earnings Report Hormel’s Specialty Food Segment Performed Well in 3Q15
Hormel Foods Corporation, based in Austin, Minnesota, is a multinational manufacturer and marketer of consumer-branded food and meat products.Earnings Report Analysts Expect Positive Revenue Growth in Fiscal 2Q16
The revenue estimate for Farmer Brothers in fiscal 2Q16 isn’t as high. However, it’s still positive. Analysts predict revenue of $145.3 million for fiscal 2Q16Earnings Report Will Bunge’s Acquisitions Help Revive Its Segment Margins?
Bunge North America, the North American operating segment of Bunge Limited (BG), announced that it had acquired Whole Harvest Foods.Cannabis Marijuana Movement: Why Do Celebrities Support It?
Marijuana is gaining more and more attention. What’s caught the most attention is that many celebrities are joining the growing support movement.Consumer How’s ADM Advancing with Its Portfolio Management Strategy?
As part of its portfolio management strategy, Archer Daniels Midland (ADM) sold its Brazilian sugar cane ethanol operations.Materials Will IIPR Still Be an Investor Favorite Post Q3 Earnings?
Innovative Industrial Properties (IIPR) is set to report its third-quarter results tomorrow. IIPR stock, up 67.2% year-to-date, has been investor favorite.Cannabis What Does President Trump Think about Marijuana?
President Trump hasn’t directly supported or opposed marijuana. In the past, he said that marijuana makes people “lose IQ points.”Cannabis Aurora Cannabis’s Revenue: Here’s What Analysts Expect
Aurora Cannabis is set to release its fiscal 2020 first-quarter earnings results on November 11. Let’s see what analysts expect for its upcoming quarter.Cannabis Marijuana Policy: Can California Shape It for the US?
Marijuana reform has always been important in California, which became the first state to legalize medical marijuana in 1996.Cannabis Cannabis Industry Heats Up, Trump Might Ban Vaping
Cannabis legalization is heating up. More states are coming forward to legalize marijuana. Cannabis is also gaining global popularity.Cannabis Cannabis Investment: How to Buy ACB, CGC, and Other Stocks
Cannabis is a hot sector that’s constantly evolving. Right now, how to buy cannabis stocks is a question that’s likely on many investors’ minds.Cannabis Cannabis in Mexico: Legalization Bill Is Ready for Voting!
Cannabis legalization is approaching the deadline in Mexico. According to the Supreme Court, the deadline for marijuana legalization is Wednesday.Cannabis Mexico Will Attempt to Legalize Marijuana in 2020
Mexico is ready with a revised proposal to legalize marijuana this year. The Supreme Court gave lawmakers until April 30 to submit the new proposal.Cannabis Canopy Growth Looks for CEO, Linton Gets a New Role
Canopy Growth took the market by surprise and let CEO Bruce Linton go. After leaving Canopy Growth, Linton joined three companies in an advisory role.Cannabis HEXO: Analysts’ Target Price and Ratings
CIBC downgraded HEXO to “neutral” from “outperform” and reduced the target price to 8.5 Canadian dollars from 9.5 Canadian dollars.Cannabis Cronos Group Joins Altria to Bet on Cannabidiol Market
Cannabis company Cronos Group has expanded its presence in the US cannabidiol market through a tie-up with tobacco company Altria Group.Cannabis Why Canopy Growth Isn’t Happy with Apple
Apple removed 181 vaping-related apps due to the vape crisis in the US. Canopy Growth is not happy with Apple’s move. Let’s see why.Consumer Archer Daniels Midland Stock Gained since Its 1Q16 Earnings
Archer Daniels Midland (ADM) is slated to report its 2Q16 results on August 2 before the market opens. The stock has gained 12% since its last quarter results.Cannabis South Dakota Plans for Marijuana Legalization amid COVID-19
Marijuana is illegal in South Dakota. However, the state decided to make both recreational and medical marijuana legal this year.Cannabis Is Aphria a Good Cannabis Pick for 2020?
Aphria has successfully strengthened its position not only in Canada but also in international markets. The company reported impressive second-quarter results.Cannabis Will MedMen Deliver Any Good News in Its Q2 Earnings?
MedMen will report its earnings results for the second quarter of fiscal 2020 on Wednesday. Analysts expect 67.6% YoY revenue growth.Cannabis Cannabis 2.0: Aphria Gets Ready for Edibles Market
Cannabis 2.0 legalization will take place in Canada this month. Aphria plans to expand its consumer base in the vape and concentrates business.Cannabis Elizabeth Warren Unveils Plan for Marijuana Legalization
According to Warren’s new marijuana plan, the federal legalization process would start within 100 days of her taking office.Cannabis Marijuana Industry: Opportunities in California amid COVID-19
Marijuana is an old but growing market in California. Notably, California became the first state to legalize medical marijuana in 1996.Cannabis Medical Cannabis in Brazil Is Coming
According to a Reuters report on December 3, Brazil is ready to approve medical cannabis products. Currently, cannabis is illegal in Brazil.Cannabis Cannabis Sector 2019 Review and 2020 Outlook
Canada legalized cannabis in October 2018, so investors expected 2019 to drive marijuana sales. However, the fate of the industry took a sharp turn.Cannabis Marijuana: Will Trump Have an Edge over Biden?
With Biden strongly opposing full-scale legalization, President Trump could turn around things. President Trump might support medical marijuana legalization.Earnings Report Why Bunge Might Report a Drop in Revenue in 1Q16
Analysts are expecting revenue to be $10.1 billion for fiscal 1Q16. This represents a fall of 6% compared to 1Q15 revenue of $10.8 billion.Cannabis Marijuana Legalization: South Dakota Does What Trump Said!
Marijuana legalization is ramping up. Now, South Dakota is taking President Trump’s advice. The state is kicking off a petition to legalize cannabis.Cannabis Vaping Concerns Grow, FDA and FTC Investigate Juul
Vaping has become very popular. However, investigations by the FTC and FDA sparked more concerns. Juul’s vaping devices could cause seizures.Consumer Wall Street Analysts’ Take on Bunge before Its 2Q16 Earnings
Around 61% of analysts now rate Bunge as a “buy” and 39% rate it as a “hold.” No analysts rate it as a “sell.”Cannabis Cannabis 3.0: Is It on the Horizon?
On October 17, Cannabis 2.0 legalized edibles, beverages, and concentrates in Canada. As the country waits for the benefits, is Cannabis 3.0 next?Cannabis Marijuana: Why Is Washington Changing Its Laws?
In 2012, Washington was the second state to legalize recreational marijuana. Now, the state plans to revamp its marijuana laws.Macroeconomic Analysis How Was 2017 for European Markets?
At the start of 2017, elections in many European countries brought some political uncertainty to the European markets.Cannabis Marijuana in Texas: Five Things You Should Know
Marijuana laws are pretty strict in Texas, but could this change? Here are five things you need to know about the state’s relationship with marijuana.Cannabis Why Canopy Growth Is Partnering with Drake
The Canadian Press reported that Canopy Growth is partnering with rapper Drake to launch a new cannabis venture, the More Life Growth Company.Cannabis Cannabis 2.0 Legalization: Canada Is Ready
Federally, cannabis legalization saw daylight in Canada in 2018. The Cannabis Act legalized recreational marijuana in October 2018. Now, the country is all set for the second wave of legalization, Cannabis 2.0, which includes cannabis edibles, cannabis-infused beverages, extracts, and various other products. Let’s dig into this more. Canada’s second wave of legalization Next month, […]Cannabis Cannabis 2.0: Aurora Cannabis Gears Up for Edibles Market
Cannabis 2.0 legalization will take place in Canada next month. Cannabis players are gearing up to expand in the edibles market.Cannabis Why Aurora Cannabis Wants to Grow Cannabis Outdoors
Aurora Cannabis (ACB) wants to grow cannabis outdoors. In July, it received Health Canada licenses for outdoor cultivation at two Canadian sites.Cannabis Is Aurora Cannabis Ready for Cannabis 3.0?
Aurora Cannabis (ACB) is ready to launch its new products for Cannabis 2.0. But is the company ready for the next phase? Let’s find out.Cannabis Cannabis Legalization: The World Waits for the US
Cannabis legalization is spreading its roots globally. Considering that other countries are legalizing marijuana, will the US follow suit?Cannabis What’s Canopy Growth Strategy for Growth?
Canopy Growth has struggled this year. Despite all their strategies, cannabis companies have failed to hit revenue and profitability targets this year.Materials IIPR, CRON, TLRY Surging: A Good Day for Cannabis Stocks
It looks like cannabis stocks had a great day. Innovative Industrial Properties (IIPR), Cronos Group (CRON), and Tilray (TLRY) are all surging today.Cannabis Marijuana Legalization: What’s Happening in Utah?
Recreational cannabis isn’t legal in Utah. Although the state legalized medical cannabis in 2018, the medical marijuana program will go live in March 2020.Cannabis Aurora Cannabis: Is This the Right Time to Invest?
Amid a subdued cannabis sector, Aurora Cannabis (ACB) stock has taken a serious hit and is down 36.4% this month. Is this the right time to invest?Cannabis Will Marijuana Stocks Continue to Surge in June?
May was an earnings month for many marijuana companies. Notably, US companies showed better revenue growth than their Canadian peers.Consumer What Are Analysts’ Target Prices before ADM’s 2Q16 Results?
Around 77% of the analysts rate Archer Daniels Midland a “hold” and 23% gave it a “buy” rating. No analysts rated it as a “sell.”